FDA draft guidance to improve clinical trial diversity: Opportunities for pharmacoepidemiology.

Russell, Elizabeth S; Aubrun, Elodie; Moga, Daniela C; Guedes, Sandra; Camelo Castillo, Wendy; Hardy, Janet R; Cole, J Alexander; Jagun, Oladayo.

Afiliação

Russell ES; Merck & Co., Inc., Rahway, NJ, USA.
Aubrun E; Novartis Pharma AG, Basel, Switzerland.
Moga DC; University of Kentucky, College of Pharmacy, Lexington, KY, USA.
Guedes S; Ferring Pharmaceuticals A/S, Copenhagen, Denmark.
Camelo Castillo W; University of Maryland School of Pharmacy, Baltimore, MD, USA.
Hardy JR; Biohaven Pharmaceuticals Holding Company Ltd., New Haven, CT, USA.
Cole JA; Alexion - AstraZeneca Rare Disease, Boston, MA, USA.
Jagun O; Pfizer Inc., New York, NY, USA.

J Clin Transl Sci ; 7(1): e101, 2023.

Article em En | MEDLINE | ID: mdl-37251002